Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Chemesis International Inc CADMF

Healthcare Drug Manufacturers - Major Cannabis
"Chemesis International Inc. is a vertically integrated global leader in the cannabis industry, currently operating within California, Puerto Rico, and Colombia. Chemesis is developing a strong foothold in key markets, from cultivation to manufacturing, distribution and retail. Chemesis has facilities in both Puerto Rico and California, allowing for cost-effective production and distribution of its products. In addition, Chemesis leverages exclusive brands and partnerships and uses the highest q


OTCPK:CADMF - Post by User

Chemesis International Inc > NEWS OUT!!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by Slyincalgaryon Dec 11, 2018 4:55pm
64 Views
Post# 29099768

RE:NEWS OUT!!

RE:NEWS OUT!! Nice to see that again they are low balling revenues on their investor presentation. That revenue works out to a run rate of a million per quarter out of Puerto Rico and the investor's presentation only guided 2.1.

The other very important aspect of the release is the the growth in PR approvals of 5000 new applicants for medical MJ use a month. Nice growth for the smallest arm of CSI's businesses currently.

Looking forward to more updates!

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities